| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1027089927 |
| P356 | DOI | 10.1038/NATURE10615 |
| P698 | PubMed publication ID | 22158250 |
| P5875 | ResearchGate publication ID | 51868244 |
| P50 | author | James R. Woodgett | Q39182989 |
| Tomasz Jaworski | Q58380674 | ||
| P2093 | author name string | Satish Patel | |
| Fred Van Leuven | |||
| Ilse Dewachter | |||
| Peter Borghgraef | |||
| Anna Kremer | |||
| Herman Devijver | |||
| David Demedts | |||
| Benoit Lechat | |||
| Maarten Gees | |||
| Seb Kügler | |||
| P2860 | cites work | Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain | Q28137790 |
| GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides | Q28205921 | ||
| Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein | Q28260479 | ||
| Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain | Q28472669 | ||
| Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice | Q30481353 | ||
| Abnormalities in brain structure and behavior in GSK-3alpha mutant mice | Q30485018 | ||
| AAV-tau mediates pyramidal neurodegeneration by cell-cycle re-entry without neurofibrillary tangle formation in wild-type mice | Q33507908 | ||
| Pathological Hallmarks, Clinical Parallels, and Value for Drug Testing in Alzheimer's Disease of the APP[V717I] London Transgenic Mouse Model | Q34127547 | ||
| GSK-3 is essential in the pathogenesis of Alzheimer's disease. | Q36568147 | ||
| Alzheimer's disease: old problem, new views from transgenic and viral models | Q37717821 | ||
| Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. | Q42675168 | ||
| Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice. | Q53237934 | ||
| Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments | Q59488574 | ||
| P433 | issue | 7376 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | E4-5; discussion E6 | |
| P577 | publication date | 2011-12-07 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | GSK-3α/β kinases and amyloid production in vivo | |
| P478 | volume | 480 |
| Q46193130 | A Chemical-Genetic Approach Reveals the Distinct Roles of GSK3α and GSK3β in Regulating Embryonic Stem Cell Fate |
| Q42069680 | A three-dimensional human neural cell culture model of Alzheimer's disease |
| Q37386311 | Accelerated colorimetric immunosensing using surface-modified porous monoliths and gold nanoparticles |
| Q38945980 | BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells. |
| Q28577666 | Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains |
| Q26749755 | Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT |
| Q28553790 | Ethyl Pyruvate Combats Human Leukemia Cells but Spares Normal Blood Cells |
| Q37569915 | GSK-3β and MMP-9 Cooperate in the Control of Dendritic Spine Morphology |
| Q92700771 | GSK-3β at the Intersection of Neuronal Plasticity and Neurodegeneration |
| Q40963450 | GSK3 as a Sensor Determining Cell Fate in the Brain |
| Q48295081 | GSK3β Controls mTOR and Prosurvival Signaling in Neurons |
| Q60594491 | GSK3β activity alleviates epileptogenesis and limits GluA1 phosphorylation |
| Q36187501 | Herpes Simplex Virus type-1 infection induces synaptic dysfunction in cultured cortical neurons via GSK-3 activation and intraneuronal amyloid-β protein accumulation |
| Q30530899 | Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes |
| Q48460242 | Inhibition of Wnt signaling induces amyloidogenic processing of amyloid precursor protein and the production and aggregation of Amyloid-β (Aβ)42 peptides |
| Q36526315 | Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies |
| Q38724561 | LISPRO mitigates β-amyloid and associated pathologies in Alzheimer's mice. |
| Q35228923 | Loss of neuronal GSK3β reduces dendritic spine stability and attenuates excitatory synaptic transmission via β-catenin |
| Q57037534 | Mini-GAGR, an intranasally applied polysaccharide, activates the neuronal Nrf2-mediated antioxidant defense system |
| Q38209971 | Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders. |
| Q36898190 | Neurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase |
| Q38149943 | New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease. |
| Q37610545 | Novel Phospho-Tau Monoclonal Antibody Generated Using a Liposomal Vaccine, with Enhanced Recognition of a Conformational Tauopathy Epitope |
| Q47107778 | Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update. |
| Q36297029 | Polo-like kinase 2 phosphorylation of amyloid precursor protein regulates activity-dependent amyloidogenic processing |
| Q34283149 | Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease |
| Q58585886 | Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease |
| Q36012200 | Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease |
| Q36172880 | Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis |
| Q34737538 | Tauopathy differentially affects cell adhesion molecules in mouse brain: early down-regulation of nectin-3 in stratum lacunosum moleculare |
| Q35622023 | Templated misfolding of Tau by prion-like seeding along neuronal connections impairs neuronal network function and associated behavioral outcomes in Tau transgenic mice |
| Q47880863 | Terminal hypothermic Tau.P301L mice have increased Tau phosphorylation independently of glycogen synthase kinase 3α/β. |
| Q57177786 | The cholinergic system in the pathophysiology and treatment of Alzheimer's disease |
| Q38736271 | The rise and fall of insulin signaling in Alzheimer's disease |
| Q26777969 | The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease |
| Q92833446 | Three-dimensional modeling of human neurodegeneration: brain organoids coming of age |
| Q38101982 | Understanding the relationship between GSK-3 and Alzheimer's disease: a focus on how GSK-3 can modulate synaptic plasticity processes |
| Q50461171 | Wnt/β-catenin signaling inhibits the Shh pathway and impairs tumor growth in Shh-dependent medulloblastoma |
Search more.